載入...
p53 at the crossroads of MPN treatment
In this issue of Blood, Lu et al describe the cooperation between an orally bioavailable mouse double minute 2 (MDM2) antagonist (RG7112) and the pegylated interferon α (Peg-IFNα 2a) to target JAK2V617F hematopoietic progenitors and stem cells. Their work provides a rationale for the treatment of pa...
Na minha lista:
| 主要作者: | |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Society of Hematology
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4118478/ https://ncbi.nlm.nih.gov/pubmed/25082860 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2014-06-579623 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|